Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion.
about
ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signalingCancer Stem Cell Hierarchy in Glioblastoma MultiformeRedox Modulating NRF2: A Potential Mediator of Cancer Stem Cell ResistanceCommon stemness regulators of embryonic and cancer stem cellsThe network of pluripotency, epithelial-mesenchymal transition, and prognosis of breast cancerPancreatic cancer stem cells: emerging target for designing novel therapyMiR-7 promotes epithelial cell transformation by targeting the tumor suppressor KLF4Induction of cancer stem cell properties in colon cancer cells by defined factorsKrüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cellsAutochthonous mouse melanoma and mammary tumors do not express the pluripotency genes Oct4 and NanogDeficiency of the Kruppel-like factor KLF4 correlates with increased cell proliferation and enhanced skin tumorigenesisTranscriptomic Analysis Shows Decreased Cortical Expression of NR4A1, NR4A2 and RXRB in Schizophrenia and Provides Evidence for Nuclear Receptor DysregulationJNK/SAPK Signaling Is Essential for Efficient Reprogramming of Human Fibroblasts to Induced Pluripotent Stem CellsNF-κB regulates mesenchymal transition for the induction of non-small cell lung cancer initiating cells.Interplay between arginine methylation and ubiquitylation regulates KLF4-mediated genome stability and carcinogenesis.Long non-coding RNAs in stem cells and cancer.The Transcription Regulator Krüppel-Like Factor 4 and Its Dual Roles of Oncogene in Glioblastoma and Tumor Suppressor in Neuroblastoma.Krüppel-like factor 4 (KLF4) regulates the miR-183~96~182 cluster under physiologic and pathologic conditions.Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma CellsKLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth.Biomarkers to Target Heterogeneous Breast Cancer Stem CellsExpression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.Mammary cancer chemoprevention by withaferin A is accompanied by in vivo suppression of self-renewal of cancer stem cellsHigh KLF4 level in normal tissue predicts poor survival in colorectal cancer patientsKrüppel-like factor 4 mediates lysophosphatidic acid-stimulated migration and proliferation of PC3M prostate cancer cells.The use of small molecules in somatic-cell reprogramming.Elevated Krüppel-like factor 4 transcription factor in canine mammary carcinomaDoxycycline inducible Krüppel-like factor 4 lentiviral vector mediates mesenchymal to epithelial transition in ovarian cancer cells.Integrative eQTL-based analyses reveal the biology of breast cancer risk lociUncoupled embryonic and extra-embryonic tissues compromise blastocyst development after somatic cell nuclear transfer.Expression of Kruppel-like factor KLF4 in mouse hair follicle stem cells contributes to cutaneous wound healing.A pan-cancer modular regulatory network analysis to identify common and cancer-specific network components.The transcription factor KLF4 as an independent predictive marker for pathologic complete remission in breast cancer neoadjuvant chemotherapy: a case-control studyEpigallocathechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell linesKrüppel-like factor 4 induces apoptosis and inhibits tumorigenic progression in SK-BR-3 breast cancer cells.Survival of cancer stem cells under hypoxia and serum depletion via decrease in PP2A activity and activation of p38-MAPKAPK2-Hsp27.Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m⁶A-demethylation of NANOG mRNA.2-(4-Hydroxy-3-methoxyphenyl)-benzothiazole suppresses tumor progression and metastatic potential of breast cancer cells by inducing ubiquitin ligase CHIP.Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4.KLF4 overexpression and apigenin treatment down regulated anti-apoptotic Bcl-2 proteins and matrix metalloproteinases to control growth of human malignant neuroblastoma SK-N-DZ and IMR-32 cells
P2860
Q21131951-474E2BC3-2B62-4D92-B3A1-E2EFEE197BC9Q26752312-3E5B00DB-B07E-44D1-806E-BEF111B7A920Q26774916-99BE2694-0369-49F3-99EB-4118477914A6Q26777882-3A726D1F-A9D6-45F7-9F8B-6D6E2ABFD481Q26785448-CCC886FB-0A02-4B4C-801D-3A5255E7C14CQ26863365-24677F13-5B97-486D-898A-EAE124CF9ECBQ27316708-832747D1-4C78-41E8-B1D3-85610CD1848BQ27320228-0DB059BE-1AF6-4C33-9D49-672045ECC219Q28486138-A42B15FF-2942-4C74-BDD6-989F11E917A1Q28487410-BA55E1F1-4020-4CE7-A2B7-FB2B5D5DC4B5Q28504494-23544768-42D9-41C3-99A4-5577181AEDD4Q28555095-6E8B1804-E66C-4053-B0B7-5F9EBBBD7136Q28830469-0B45F04D-1750-41B2-96B6-6A0F6F18C0E5Q30417710-7C1CDBF6-2FB2-41E3-B31C-58F6234B749BQ30667326-1809D866-6E93-42D7-A774-A4CD7694DA88Q33585055-2E546740-56E7-44BD-A435-34C009A82A15Q33652886-9E18041B-D0D9-4979-9A65-3978C73DC83AQ33688638-8B2EB316-9814-42C4-A358-25FD847DB95AQ33795254-10D85D4B-4308-4D3A-BF19-AB7AD9C6A5ECQ33809921-B3EBF843-F970-49B8-BEAB-0E1C510A0052Q33811149-32FF1506-332D-4304-9FC9-4DCA905D8164Q33829480-F3B26C6C-ADD6-4202-9933-AC3C8A8FF49FQ33853018-72910BF8-7BAE-43B6-9D83-1A4D7645C2E0Q33990397-BBB76BDB-F189-4343-AC9F-8A12C30B0512Q33990560-5EAC88E9-1DE1-4D15-924F-3C2C6249F209Q34038758-A962EA0C-7AED-4D69-B6BC-223156525927Q34042124-3348977E-69FB-4EA5-8F83-72BBD3C026D2Q34066627-1D66189F-DC8B-4CCC-8189-B1F32C2C4E28Q34194768-8E209CB7-91B5-40B3-86FF-BFA8FA6AD754Q34305387-B808CD8D-ACDF-4A42-83BD-170116C7F893Q34321610-C4048665-46A3-4A95-823D-5050A5BC9FC4Q34421629-9CA454EF-36BB-4356-9CFF-41260466F375Q34434819-AEB9C019-8FC3-4E38-A53C-87AF9EB4F097Q34461440-A2105A4C-B7FC-4CEE-BA24-869084D04692Q34469953-0911D945-B14F-4F66-A58B-BE351116E39DQ34490253-A0DB218E-0850-4559-BBDE-14DC64F09C8CQ34519307-B864E0AB-4D55-4B17-AA1A-4555A2289518Q34530928-31BCB9FE-0636-4CB6-90A4-A1695CC3BEE6Q34539750-09AD2867-CFDF-4C58-A1F2-AC44177F8148Q34547607-A50C352D-75E7-481F-9056-12CA18C5EBFF
P2860
Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Kruppel-like factor 4 (KLF4) i ...... r cell migration and invasion.
@ast
Kruppel-like factor 4 (KLF4) i ...... r cell migration and invasion.
@en
type
label
Kruppel-like factor 4 (KLF4) i ...... r cell migration and invasion.
@ast
Kruppel-like factor 4 (KLF4) i ...... r cell migration and invasion.
@en
prefLabel
Kruppel-like factor 4 (KLF4) i ...... r cell migration and invasion.
@ast
Kruppel-like factor 4 (KLF4) i ...... r cell migration and invasion.
@en
P2093
P2860
P356
P1433
P1476
Kruppel-like factor 4 (KLF4) i ...... r cell migration and invasion.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2010.591
P407
P577
2011-01-17T00:00:00Z
P5875
P6179
1024923159